Senior International Leadership Role - Myelofibrosis Treatment
In this senior international leadership position, you will shape and steer the global launch strategy for a transformative new treatment in myelofibrosis, driving impact across diverse markets and healthcare systems.
You’ll bring together scientific insight, commercial excellence, and deep cross‑functional collaboration to ensure strong, timely market entry and sustained growth. Working closely with international and country teams, you will guide strategic decision-making, integrate market and customer insights, and foster a culture of innovation that elevates patient access and strengthens leadership in hematology.
This is a unique opportunity to influence the entire journey from development to commercialization while empowering teams across regions to make a meaningful difference for patients living with serious blood cancers.
Location: Basel, Switzerland
#LI-Hybrid
Major Accountabilities:
- Lead the international launch strategy for a new myelofibrosis treatment, ensuring alignment with hematology objectives.
- Orchestrate cross‑functional collaboration across medical, regulatory, access, commercial, and supply teams to enable seamless execution.
- Drive launch readiness across priority markets, identifying risks early and enabling effective mitigation plans.
- Integrate market insights, competitive intelligence, and stakeholder feedback to refine global positioning and messaging.
- Partner with regional and country teams to support localized execution and ensure alignment with global strategy.
- Define, track, and govern critical launch milestones and performance indicators to enable timely decisions.
- Engage senior leaders with clear communication on vision, progress, and strategic priorities across international markets.
- Uphold strong standards of compliance, operational excellence, and best practices in launch execution.
- Influence development planning by shaping target product profiles and evidence needs to optimize market access potential.
- Lead commercialization excellence initiatives and elevate customer‑centric engagement approaches across regions.
Essential Requirements:
- Recent, significant Profit and Loss (P&L) leadership experience at the country level.
- Approximately 15 years of progressive commercial experience across country and above‑country roles.
- Proven success leading launches and shaping therapeutic area strategy across diverse international markets.
- Strong understanding of hematology or related specialty areas, with experience translating scientific insights into strategic plans.
- Demonstrated ability to lead in complex, fast‑evolving environments and deliver results across high‑growth markets.
- Expertise in turning scientific data into differentiated value propositions across pre‑launch and lifecycle management phases.
- Consistent record of influencing cross‑unit and cross‑functional teams to achieve shared strategic goals.
- Ability to integrate multiple market insights and stakeholder perspectives to guide clear, evidence‑based decision‑making.
Desirable Requirements:
- Proven ability to lead and inspire diverse, cross‑regional teams, fostering collaboration, clarity, and strategic alignment across complex environments.
- Demonstrated strength in influencing senior stakeholders and navigating matrixed structures to drive shared priorities and long‑term business impact.
Apply online using the form below. Please note that only applications matching the job profile will be considered.